Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Over the long term, broad indices tend to outperform many active strategies due to lower costs and market-wide diversification.
27,915 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A major energy infrastructure company is funding AI data-center expansion with a generous dividend, while C3.AI conte...
Housing costs are rising not only from prices but from the way homes are built and financed. This report explains how...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...
When Bam Margera was invited to the final Jackass premiere but won’t attend, it offers more than celebrity gossip. Th...
A notable fund just built a fresh position in a cloud security leader. Discover the numbers behind winmill loads qual...
A 24-year-old youth pastor questions whether retirement is feasible on a $2,000 monthly income. Experts urge prioriti...
When a company executive moves tens of thousands of shares, it sparks questions. This guide explains what insider sel...
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Every March, SCHD undergoes a careful reset. This article explains schd annual reconstitution: here's how the process...
As markets wobble in mid-2026, retirees rethink growth bets tied to gig-economy platforms. The retirement portfolio c...